In addition, G-CSFR mAb therapy during influenza infection in mice did not cause neutropenia or compromise viral clearance, although it was not established whether viral-induced blood neutrophilia and neutrophil trafficking into the lungs were reduced. The gene discussed is CSF3R; the disease is neutropenia.